| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corcept Therapeutics Incorporated (CORT) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 16 sells. CORT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $204.85M | -12,837 | |
| Dir | 1.15M | $91.56M | - | |
| Other | 190.0K | $15.17M | - | |
| Other | 84.0K | $6.71M | -75,000 | |
| Other | 78.6K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2018 | Gala Renee D | Director | Buy | 10,000 | $15.51 | $155,101.50 | +1,000% | |
| Feb 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $16.60 | $132,774.40 | -100% | |
| Jan 8, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $18.67 | $149,348.80 | -100% | |
| Dec 8, 2017 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $16.72 | $133,776.00 | -100% | |
| Nov 13, 2017 | Baker G Leonard Jr | Director | Sale+OE | 30,000 | $17.59 | $527,556.00 | -3.7% | |
| Jul 19, 2017 | Mahoney David L | Director | Sale+OE | 23,006 | $12.50 | $287,596.52 | -1.0% | |
| Jul 13, 2017 | Mahoney David L | Director | Sell | 6,994 | $12.50 | $87,448.23 | -0.3% | |
| May 4, 2017 | Robb Gary Charles53 | Chief Financial Officer | Buy | 5,600 | $9.75 | $54,588.24 | +445.2% | |
| Mar 16, 2017 | Enright Patrick G74 | Director | Sell | 269,955 | $9.94 | $2,683,236.76 | -4.4% | |
| Mar 15, 2017 | Enright Patrick G74 | Director | Sell | 600,000 | $10.15 | $6,092,927.07 | -2.6% |